Creating advanced DNA polymerases for faster genome assembly
Directed evolution of polymerases that can read and write extremely long sequences
This study is all about making it easier and faster to create long strands of DNA, which could help scientists working in synthetic biology build new genomes with fewer mistakes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10746455 on NIH RePORTER |
What this research studies
This research focuses on improving the process of synthesizing entire genomes by developing new DNA polymerases that can read and write very long sequences of DNA. By using a method called Compartmentalized Self-Replication, the researchers aim to enhance the efficiency of DNA amplification, allowing for the creation of long DNA fragments with fewer errors. This could significantly reduce the time and effort required to assemble new chromosomes or genomes, making the process more accessible and efficient for various applications in synthetic biology.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with genetic disorders that could be addressed through advanced genome editing techniques.
Not a fit: Patients with conditions that do not involve genetic mutations or those not related to genome assembly may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate methods for genome assembly, benefiting advancements in genetic engineering and synthetic biology.
How similar studies have performed: Other research in synthetic biology has shown promising results with similar approaches, indicating potential for success in this novel application.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Ellington, Andrew D — University of Texas at Austin
- Study coordinator: Ellington, Andrew D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.